Literature DB >> 7744421

Quercetin and kaempherol: an argument against the use of podophyllin?

C S Petersen1, K Weismann.   

Abstract

INTRODUCTION: Topical application of podophyllin is a routine procedure in patients with ano-genital warts. Podophyllin is a crude plant extract and is therefore not a well-defined product. It may contain variable amounts of the active lignan podophyllotoxin and the majority of the dry weight of podophyllin is made up of substances never identified.
OBJECTIVE: The purpose of the study was to estimate in podophyllin 20% the amounts of two mutagenic substances, quercetin and kaempherol.
METHODS: Using high-pressure liquid chromatography the amounts of quercetin and kaempherol were determined in 3 batches of podophyllin 20%.
RESULTS: Quercetin and kaempherol constitutes 2.5-3.8% and 6.0-6.4% of podophyllin dry substance, respectively. Podophyllotoxin constitutes in comparison 12.7-13.8% of podophyllin dry substance.
CONCLUSION: As approximately 10% of the amount of dry substance in podophyllin 20% is composed of two mutagenic flavonoids, quercetin and kaempherol, efforts should be focused on the production of a well-defined purified podophyllotoxin preparation that may replace podophyllin for clinic use in patients with genital warts. Self-medication with purified podophyllotoxin 0.5% may be considered as first-line treatment in well-instructed patients with external genital warts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7744421      PMCID: PMC1195461          DOI: 10.1136/sti.71.2.92

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  9 in total

1.  The biological effects and the chemical composition of podophyllin: a review.

Authors:  M KELLY; J L HARTWELL
Journal:  J Natl Cancer Inst       Date:  1954-02       Impact factor: 13.506

2.  Identification of mutagens in Japanese pickles.

Authors:  S Takenaka; N Sera; H Tokiwa; I Hirohata; T Hirohata
Journal:  Mutat Res       Date:  1989-05       Impact factor: 2.433

Review 3.  Papillomas and cancer in cattle.

Authors:  M S Campo
Journal:  Cancer Surv       Date:  1987

4.  The effect of podophyllotoxin on the skin of the mouse, with reference to carcinogenic, cocarcinogenic, and anticarcinogenic action.

Authors:  I BERENBLUM
Journal:  J Natl Cancer Inst       Date:  1951-02       Impact factor: 13.506

5.  A double-blind, randomized trial of 0.5% podofilox and placebo for the treatment of genital warts in women.

Authors:  M D Greenberg; L H Rutledge; R Reid; N R Berman; S L Precop; R K Elswick
Journal:  Obstet Gynecol       Date:  1991-05       Impact factor: 7.661

6.  Patient-applied podofilox for treatment of genital warts.

Authors:  K R Beutner; M A Conant; A E Friedman-Kien; M Illeman; N N Artman; R A Thisted; D H King
Journal:  Lancet       Date:  1989-04-15       Impact factor: 79.321

7.  Mutagenicity of plant flavonols in the Salmonella/mammalian microsome test: activation of flavonol glycosides by mixed glycosidases from rat cecal bacteria and other sources.

Authors:  J P Brown; P S Dietrich
Journal:  Mutat Res       Date:  1979-03       Impact factor: 2.433

8.  The effects of resin of podophyllin on condyloma acuminatum.

Authors:  T R Wade; A B Ackerman
Journal:  Am J Dermatopathol       Date:  1984-04       Impact factor: 1.533

9.  Topical treatment of penile condylomata acuminata with podophyllin, podophyllotoxin and colchicine. A comparative study.

Authors:  G von Krogh
Journal:  Acta Derm Venereol       Date:  1978       Impact factor: 4.437

  9 in total
  8 in total

1.  The management of anogenital [correction of anal] warts.

Authors:  R Maw; G von Krogh
Journal:  BMJ       Date:  2000-10-14

Review 2.  Podophyllin office therapy against condyloma should be abandoned.

Authors:  G von Krogh; E Longstaff
Journal:  Sex Transm Infect       Date:  2001-12       Impact factor: 3.519

3.  European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts.

Authors:  G von Krogh; C J Lacey; G Gross; R Barrasso; A Schneider
Journal:  Sex Transm Infect       Date:  2000-06       Impact factor: 3.519

4.  Podophyllin 0.5% or 2.0% v podophyllotoxin 0.5% for the self treatment of penile warts: a double blind randomised study.

Authors:  D J White; C Billingham; S Chapman; S Drake; D Jayaweera; S Jones; A Opaneye; C Temple
Journal:  Genitourin Med       Date:  1997-06

Review 5.  Warts (genital).

Authors:  Henry W Buck
Journal:  BMJ Clin Evid       Date:  2010-08-13

Review 6.  Topical imiquimod: a review of its use in genital warts.

Authors:  C M Perry; H M Lamb
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

Review 7.  Warts (genital).

Authors:  Henry W Buck
Journal:  BMJ Clin Evid       Date:  2007-08-01

Review 8.  [Virus-induced anorectal diseases. Condylomata acuminata and herpes simplex].

Authors:  V Wienert
Journal:  Hautarzt       Date:  2004-03       Impact factor: 0.751

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.